Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

20.35
+5.0332.83%
Post-market: 20.350.00000.00%16:02 EDT
Volume:2.01M
Turnover:41.05M
Market Cap:587.55M
PE:-110.31
High:21.33
Open:19.85
Low:18.68
Close:15.32
Loading ...

Castle Biosciences enters collaboration, license agreement with SciBase

TIPRANKS
·
17 Jun

Castle Biosciences Inc. Announces Collaboration with SciBase for Development of Diagnostic Test Predicting Atopic Dermatitis Flares

Reuters
·
17 Jun

Castle Biosciences CEO Derek Maetzold to Participate in Panel Discussion at 2025 BIO International Convention

Reuters
·
11 Jun

Castle Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
24 May

Castle Biosciences Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
21 May

Castle Biosciences price target lowered to $40 from $44 at Scotiabank

TIPRANKS
·
21 May

Castle Biosciences Inc. to Present at the 2025 Jefferies Global Healthcare Conference

Reuters
·
21 May

U.S. RESEARCH ROUNDUP-Levi Strauss, Myriad Genetics, Palo Alto

Reuters
·
21 May

Castle Biosciences Is Maintained at Buy by Lake Street

Dow Jones
·
07 May

Stock Track | Castle Biosciences (CSTL) Plummets 14.21% as Q1 Earnings Fall Short of Expectations

Stock Track
·
06 May

Castle Biosciences Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
06 May

Stock Track | Castle Biosciences (CSTL) Plunges 6.13% Pre-market on Q1 Earnings Miss

Stock Track
·
06 May

Castle Biosciences to acquire Capsulomics, terms undisclosed

TIPRANKS
·
06 May

Castle Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Castle Biosciences raises FY25 revenue view to $287M-$297M from $280M-$295M

TIPRANKS
·
06 May

BRIEF-Castle Biosciences To Acquire Previse

Reuters
·
06 May

Castle Biosciences Q1 EPS $(0.20) Misses $(0.07) Estimate, Sales $88.00M Beat $80.38M Estimate

Benzinga
·
06 May

BRIEF-Castle Biosciences Q1 Basic EPS USD -0.9

Reuters
·
06 May

Castle Biosciences Reports First Quarter 2025 Results

GlobeNewswire
·
06 May

Castle Biosciences to Acquire Previse

GlobeNewswire
·
06 May